Search

Home > OIS Podcast > Can Allegro’s Integrin Peptide Therapy Help Usher in Retina 2.0 for Vitreoretinal Indications?
Podcast: OIS Podcast
Episode:

Can Allegro’s Integrin Peptide Therapy Help Usher in Retina 2.0 for Vitreoretinal Indications?
Category: Business
Duration: 00:23:22
Publish Date: 2016-07-19 23:00:00
Description: Allegro Ophthalmics’ executive team boasts a successful pedigree that began with starting ISTA and taking it public. Now, Vicken Karageozian, MD, president and CMO, says the company is six months away from receiving results from Phase II trials. Hear how the firm has advanced this promising new drug without venture capital.
Total Play: 0